Navegar por autor "CRESPO CASAL, MANUEL"

Mostrando ítems 1-6 de 6

Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial

2020- Curran, A.; Rull, A.; Navarro, J.; Vidal-González, J.; Martin-Castillo, M.; [et al.]
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

2019- Guillen, Y.; Noguera-Julian, M.; Rivera, J.; Casadella, M.; Zevin, A. S.; [et al.]
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

2019- Guillén, Yolanda; Nogueira-Julian, Marc; Rivera, Javier; Casadellá, Maria; Zevin, Alexander S; [et al.]
Mechanisms of abrupt loss of virus control in a cohort of previous HIV controllers

2019- Rosas-Umbert, M.; Llano, A.; Bellido, R.; Olvera, A.; Ruiz-Riol, M.; [et al.]
Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)

2019- Vázquez-Morón, S.; Berenguer, J.; González-García, J.; Jiménez-Sousa, M. Á; Canorea, I.; [et al.]
Switching from a protease inhibitor-based regimen to a dolutegravir-based regimen: a randomized clinical trial to determine the effect on peripheral blood and ileum biopsies from ART-suppressed HIV-infected individuals

2019- Moron-Lopez, S.; Navarro, J.; Jimenez, M.; Rutsaert, S.; Urrea, V.; [et al.]